Evoke Pharma Cash Flow Statement (2020-2025) | EVOK

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -6.97M-2.13M-2.27M-2.71M-2.29M-1.97M-1.67M-2.17M-2.23M-2.01M-1.80M-2.24M-1.87M-1.69M-1.99M-1.58M-1.27M-1.31M-1.19M-1.31M-1.57M-1.16M
Share-based Compensation 0.31M0.36M0.48M0.48M0.56M0.40M0.46M0.45M0.38M0.37M0.36M0.35M0.28M0.28M0.28M0.28M0.25M0.13M0.13M0.26M0.08M0.10M0.11M
Gains from Investment Securities 0.88M1.17M1.17M1.17M1.31M0.14M0.14M0.14M0.04M0.08M0.08M0.01M0.15M0.15M0.01M0.12M0.14M0.15M0.15M
Non-cash Items 5.13M2.58M0.01M0.42M0.01M
Cash from Operations -1.55M-1.56M-1.81M-1.71M-2.95M-1.51M-5.89M-2.00M-1.62M-1.37M-1.10M-2.51M-1.63M-1.21M-1.04M-1.11M-2.58M-0.82M-0.82M-1.24M-1.00M-0.57M-0.52M
Change in Working Capital
Change in Receivables 0.10M0.07M0.02M0.07M0.12M-0.05M0.31M-0.05M0.06M0.34M0.21M-0.56M0.78M0.55M0.02M0.40M0.09M0.39M0.29M
Change in Inventory 0.08M0.15M-0.01M-0.02M0.11M-0.04M-0.05M-0.04M0.09M0.11M-0.04M
Change in Accured Expenses -0.14M-0.35M0.13M0.61M-0.60M-0.20M-0.03M0.31M0.06M-0.12M0.21M-0.09M0.25M0.23M-0.02M0.19M-1.06M0.16M0.16M1.49M-0.49M1.74M0.33M
Other Working Capital Changes -0.23M-0.23M0.19M0.66M-0.02M-0.28M-0.30M-0.25M0.70M-0.22M-0.30M-0.23M0.72M-0.33M-0.24M-0.15M
Financing Activities
Other financing activities 0.01M0.15M0.43M1.00-1.00
Cash from Financing Activities 0.02M5.41M0.10M3.50M13.07M0.05M0.31M0.17M7.12M7.54M0.30M2.98M3.50M0.02M0.04M
Additional items
Change in Cash -1.53M3.86M-1.71M1.79M10.12M-1.47M-5.58M-2.00M-1.44M5.75M-1.10M-2.51M-1.63M-1.21M-1.04M-1.23M4.96M-0.52M2.16M2.26M-0.97M-0.57M-0.48M
Free Cash Flow -1.55M-1.56M-1.81M-1.71M-2.95M-1.51M-5.89M-2.00M-1.62M-1.37M-1.10M-2.51M-1.63M-1.21M-1.04M-1.11M-2.58M-0.82M-0.82M-1.24M-1.00M-0.57M-0.52M
Net Cash Flow -1.53M3.86M-1.71M1.79M10.12M-1.47M-5.58M-2.00M-1.44M5.75M-1.10M-2.51M-1.63M-1.21M-1.04M-1.11M4.96M-0.52M2.16M2.26M-0.97M-0.57M-0.48M